Skip to main content

West Pharmaceutical Services Value Stock - Dividend - Research Selection

West pharmaceutical services

ISIN: US9553061055 , WKN: 864330

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


1 S&P 500 Stock on Our Watchlist and 2 We Find Risky

2026-03-05
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.

Top 50 High-Quality Dividend Growth Stocks For March 2026

2026-03-03

ALGN vs. WST: Which Stock Is the Better Value Option?

2026-03-03
ALGN vs. WST: Which Stock Is the Better Value Option?

Is West Pharmaceutical Services (WST) Pricing Too Much Growth Into Its Current Share Price?

2026-02-28
If you are wondering whether West Pharmaceutical Services at around US$254 per share is offering fair value or stretching expectations, you are not alone. The stock has recently shown mixed performance, with a 5.5% gain over the past 7 days and 7.8% over 30 days, but a year to date return of an 8.0% decline and a 22.1% decline over 3 years. Over the last 12 months the share price return sits at 9.9%, while the 5 year return is a 1.8% decline. Together, these figures suggest a story that is...

Why West Pharmaceutical (WST) Is Up 5.5% After New US$1 Billion Buyback And Dividend Increase

2026-02-28
In February 2026, West Pharmaceutical Services’ Board authorized a new share repurchase program of up to US$1.00 billion with no expiration date and declared a regular quarterly dividend of US$0.22 per share, payable on May 6, 2026 to shareholders of record on April 29, 2026. This renewed commitment to buybacks and dividends, following full use of the prior repurchase program, highlights how management is currently prioritizing returning excess cash to shareholders. With this sizable new...

Best Dividend Aristocrats For March 2026

2026-02-27
NOBL is up 9.39% YTD vs SPY’s 1.08% as Dividend Aristocrats rebound in 2026.

West to Participate in Upcoming Investor Conferences

2026-02-27
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will present at the following upcoming investor conferences:

3 Mid-Cap Stocks with Warning Signs

2026-02-26
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.

Why West Pharmaceutical Services (WST) is a Top Momentum Stock for the Long-Term

2026-02-25
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Here is Why West Pharmaceutical Services, Inc. (WST) is Strongly Favored by Hedge Funds

2026-02-24
West Pharmaceutical Services, Inc. (NYSE:WST) is one of the 10 best life sciences stocks to buy according to hedge funds. On February 17, the governing body of West Pharmaceutical Services, Inc. (NYSE:WST) approved a new share repurchase program authorizing the buyback of up to $1 billion of its common stock. The firm highlighted that the […]